Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Daily News

Steep Rise in PVAD Support for Protected PCI: Medicare Data

Caitlin E. Cox

August 19, 2022

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

Shelley Wood

July 15, 2022

News Daily News

Medtronic Recalls Batteries in Some HeartWare VAD Systems

L.A. McKeown

June 23, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Daily News

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

L.A. McKeown

April 29, 2022

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

News Daily News

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Yael L. Maxwell

March 17, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

Caitlin E. Cox

January 31, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Advertisement

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Steep Rise in PVAD Support for Protected PCI: Medicare Data

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

Medtronic Recalls Batteries in Some HeartWare VAD Systems

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Medtronic’s HeartWare HVAD Recalled for Pump Weld Defect

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content